Dear ICIS Members, Cytokine & Interferon Researchers & Industry Partners, It’s hard to believe that six months have flown by since we introduced the new, semi-monthly Signals+ in partnership with Multiview. Time truly does fly when you’re staying informed and engaged in the dynamic world of cytokine and interferon research. [READ MORE]
Submit Nomination Today Deadline to Submit Nomination or Self-Nominate: April 5, 2024 The International Cytokines & Interferon Society (ICIS) is on the lookout for outstanding individuals to fill six pivotal leadership roles. This is your chance to steer the course of our society and make a significant impact. If you [READ MORE]
The International Cytokines & Interferon Society (ICIS) thrives on the invaluable contributions of individuals who generously devote their time and expertise to the Society. As we look to the future, we invite you, our members, to consider stepping into leadership roles that will drive the field of cytokine and interferon research to new heights. [READ MORE]
In the ever-evolving realm of scientific communication, Signals+ has been a beacon for the International Cytokine & Interferon Society (ICIS) community since its inception in 1994. Founded by the esteemed Howard Young, the newsletter has been a source of insightful news, history and updates of cytokine discoveries, and even culinary delights to nourish the minds in laboratories worldwide. Last October, Signals+ underwent a significant transformation, transitioning to a semi-monthly publication under Howard’s guidance. Now, as Howard steps down, we are thrilled to introduce the new Co-Editors-in-Chief, Dr. Di Yu and Dr. Daniella M. Schwartz. [READ MORE]
The governing council of the International Cytokine & Interferon Society (ICIS) announced the Society’s ICIS-Distinguished Service Award would henceforth be known as the ICIS-Howard A. Young Distinguished Service Award in recognition of the extraordinary contributions… [READ MORE]
The International Cytokine & Interferon Society (ICIS) is embarking on an exciting new chapter with the appointment of Stephanie Flores as Co-Managing Director alongside Joan Oefner. This strategic move, announced by ICIS President Sarah Gaffen, reflects a commitment to fortify the organization’s resources, enhance member engagement, and explore new avenues for growth. [READ MORE]
The International Cytokine & Interferon Society is pleased to announce that we have partnered with North America’s largest B2B publisher, Multiview, to produce our email newsletter, Signals+. We know how important it is to have direct access to the latest information, trends, and developments in our ever-changing field of practice. [READ MORE]
Curt M. Horvath elected to the position of President-Elect of the International Cytokine & Interferon Society. [READ MORE]
We are excited to announce the results of the 2023 ICIS Leadership election! Thank you to all our candidates and the members who voted. Congratulations to these members who will begin their positions in January, with President-Elect beginning at the Annual Member’s Business Meeting in Athens on Wednesday, October 18th: [READ MORE]
At each Annual Scientific Meeting there shall be an Annual Business Meeting of the Membership of the Society, presided over by the President. Five percent of the Members shall constitute a quorum. Wishing you all a very Happy, Healthy and Successful New Year! Inviting all ICIS members and others who [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
